October 30, 2018 - "Obviousness Standard: Leveraging Latest PTO and Court Guidance -- Overcoming Challenges of Obviousness and Attacks on Patent Validity" (Strafford) - 1:00 to 2:30 pm (EDT)
October 30, 2018 - European biotech patent law update (D Young & Co) - 5:00 am, 8:00 am, and 1:00 pm (EDT)
October 30, 2018 - "University Technology Transfer and Licensing Agreements -- Determining Type of Transfer Agreement to Use, Structuring Key Provisions, Overcoming Unique Challenges" (Strafford) - 1:00 to 2:30 pm (EDT)
October 31, 2018 - "AIA Estoppel: A New Flavor of Collateral Estoppel and/or Res Judicata?" (Intellectual Property Owners Association) - 2:00 to 3:00 pm (ET)
November 1, 2018 - "When Patents Go Wrong . . . And What To Do About It" (J A Kemp) - 3:30 to 4:30 pm (Greenwich Mean Time)
November 7, 2018 - "Antibody Patenting After Amgen v. Sanofi: U.S. and European Perspectives -- Meeting Written Description and Obviousness Requirements" (Strafford) - 1:00 to 2:30 pm (EST)
November 8, 2018 - "Deciphering the PTAB's Standard Operating Procedure Changes: A Game Changer for Post-Grant Proceedings" (Technology Transfer Tactics) - 1:00 pm to 2:00 pm (ET)
Comments